6 August 2025 - The International Planned Parenthood Federation (IPPF) has learned that over $9.7 million worth of US-funded contraceptives are now set to be incinerated in France. Seventy-seven percent of these essential supplies were earmarked for five countries in the Africa Region - including the Democratic Republic of the Congo (DRC), Kenya, Tanzania, Zambia, and Mali — many of which are already facing severe humanitarian crises. The incineration of these contraceptives will deny more than 1.4 million women and girls access to life-saving care. Rather than reaching the communities who need them most, these essential medical supplies - many of which don’t expire until 2027 to 2029 - are being needlessly and egregiously destroyed.IPPF Member Associations in the affected countries were due to receive a share of these contraceptive stocks. Instead, they are now facing a sharp decline in supply following the decision to incinerate them. More than 40% of the total value of the contraceptive stockpiled in Brussels was allocated for shipment to Tanzania alone. Dr Bakari Omary, Project Coordinator at UMATI, IPPF’s Member Association in Tanzania, said:  “We are facing a major challenge. The impact of the USAID funding cuts has already significantly affected the provision of sexual and reproductive health services in Tanzania - leading to a shortage of contraceptive commodities, especially implants. This shortage has directly impacted clients' choices regarding family planning uptake.”This development adds a new layer of outrage to what is already a cruel political decision. These contraceptives were already manufactured, packaged, and ready for distribution. IPPF offered to take them for redistribution at no cost to the US taxpayer, but this offer was declined. The actions of the U.S. administration make it clear that politics trump economics, given the additional costs necessary for transportation, storage, and incineration of these products. “This decision to destroy ready-to-use commodities is appalling and extremely wasteful. These life-saving medical supplies were destined to countries where access to reproductive care is already limited, and in some cases, part of a broader humanitarian response, such as in the DRC. The choice to incinerate them is unjustifiable and undermines efforts to protect the health and rights of women and girls,” said Marie-Evelyne Petrus-Barry, Africa Regional Director of IPPF.IPPF's local partners in Africa will now face increased challenges to deliver essential and life-saving care. According to RHSC, the loss of these supplies is projected to result in 362,000 unintended pregnancies and 110,000 unsafe abortions:  Tanzania: 1,031,400 injectable contraceptives and 365,100 implants will not be distributed. These products represent over 50% of USAID annual support to Tanzania's health system and a terrifying 28% of the total annual need of the country.Mali: 1,100,880 oral contraceptives and 95,800 implants will be denied, 24% of Mali’s annual need.Zambia: 48,400 implants and 295,000 injectable contraceptives will be denied to women.Kenya: 108,000 women will not have access to contraceptive implants, 13.5% of its annual need. Nelly Munyasia, Executive Director for the Reproductive Health Network in Kenya (IPPF Member Association): “In Kenya, the effects of US funding disruptions are already being felt. The funding freeze has caused stockouts of contraceptives, leaving facilities with less than five months' supply instead of the required 15 months; reduced capacity building for health workers; disrupted digital logistics and health information systems, and caused a 46% funding gap in Kenya’s national family planning program. These systemic setbacks come at a time when unmet need for contraception remains high. Nearly 1 in 5 girls aged 15–19 is already pregnant or has given birth. Unsafe abortions remain among the five leading causes of maternal deaths in Kenya.” Sarah Durocher, President of Le Planning familial (IPPF’s French Member Association): “We call on the French government to take responsibility and act urgently to prevent the destruction of USAID-funded contraceptives. It is unacceptable that France, a country that champions feminist diplomacy, has remained silent while others, like Belgium, have stepped in to engage with the US government. In the face of this injustice, solidarity with the people who were counting on these life-saving supplies is not optional: it is a moral imperative.”“We will not stay silent while essential care is destroyed by ideology”, continued Marie-Evelyne Petrus-Barry.Notes: IPPF’s local partners in the countries affected include Reproductive Health Network Kenya, Chama cha Uzazi na Malezi Bora Tanzania, Association Malienne pour la Protection et la Promotion de la Famille, Planned Parenthood Association of Zambia, Association Burkinabé pour le Bien-Etre Familial and the Association pour le Bien-Etre Familial/Naissances Désirables.For more information or to interview one of our staff, please contact [email protected] or +66628683089. About the International Planned Parenthood Federation  IPPF is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Led by a courageous and determined group of women, IPPF was founded in 1952 at the Third International Planned Parenthood Conference. Today, we are a movement of 158 Member Associations and Collaborative Partners with a presence in over 153 countries.  Our work is wide-ranging, and includes services for sexual health and well-being, contraception, abortion care, sexually transmitted infections and reproductive tract infections, HIV, obstetrics and gynecology, fertility support, sexual and gender-based violence, comprehensive sex education, and responding to humanitarian crises. We pride ourselves on being local through our members and global through our network. At the heart of our mission is the provision of – and advocacy in support of – integrated healthcare to anyone who needs it regardless of race, gender, sex, income, and, crucially, no matter how remote. 

30 June 2025 - The International Planned Parenthood Federation (IPPF) is proud to announce the roll out of CAB-LA (cabotegravir-long acting), a form of pre-exposure prophylaxis (PrEP) for HIV, in Eswatini, and Malawi, and a pilot project in Lesotho - a major milestone in the fight against HIV. IPPF Member Associations (MAs) in the three countries - Family Life Association of Eswatini (FLAS), Lesotho Planned Parenthood Association (LPPA), and Family Planning Association of Malawi ( FPAM) will soon begin to distribute CAB-LA for HIV prevention to individuals who would like to use this form of HIV prevention.  CAB-LA, a long-acting injectable PrEP, is a game changer for HIV prevention. PrEP is an HIV prevention method where HIV-negative individuals take medication to significantly reduce their risk of acquiring HIV. Administered every 8 weeks, CAB-LA greatly reduces infection risk and does not rely on remembering to take a daily pill, addressing adherence challenges faced by some people using oral PrEP.  This roll-out comes when US budget cuts have severely impacted governments and organizations providing sexual and reproductive health services, HIV prevention, and humanitarian aid. These financial restrictions have significantly impacted access to essential sexual and reproductive health medications globally, compromising HIV prevention and treatment for many, especially those most in need. The arrival of CAB-LA is a major step forward in the fight against HIV/AIDS, providing longer-term protection, a more convenient option, and a discreet alternative to daily pills. Family Life Association of Eswatini, Lesotho Planned Parenthood Association, and the Family Planning Association of Malawi will be providing CAB-LA for PrEP through their static clinics and other public service delivery points. This effort underscores the vital role our MAs play in securing and delivering universal access to sexual and reproductive healthcare. For more information, please contact [email protected] the International Planned Parenthood Federation  IPPF is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Led by a courageous and determined group of women, IPPF was founded in 1952 at the Third International Planned Parenthood Conference. Today, we are a movement of 158 Member Associations and Collaborative Partners with a presence in over 153 countries.  Our work is wide-ranging, and includes services for sexual health and well-being, contraception, abortion care, sexually transmitted infections and reproductive tract infections, HIV, obstetrics and gynecology, fertility support, sexual and gender-based violence, comprehensive sex education, and responding to humanitarian crises. We pride ourselves on being local through our members and global through our network. At the heart of our mission is the provision of – and advocacy in support of – integrated healthcare to anyone who needs it regardless of race, gender, sex, income, and, crucially no matter how remote.  

Joint statement by FCAA, IPPF, and ILGA-World from the Kalavai Partnership31 March 2025 -  We call on policymakers, governments, and philanthropy to protect and expand HIV funding and not to turn their backs on vulnerable populations.The world is at a crossroads in the fight against HIV. For decades, dedicated investments in HIV prevention, treatment, and care have saved millions of lives and helped stabilize communities. Yet today, these gains are at risk. Critical funding from the U.S. government and other donor nations is under threat, jeopardizing the very infrastructure that has driven progress.In fact, new analyses published by amfAR and The Lancet demonstrate the catastrophic toll cuts to both the U.S. CDC Division of HIV Prevention and foreign aid from the US, the Netherlands, Britain, and other nations, predicting up to 2.9 million more HIV-related deaths before 2030 and essentially undoing all progress achieved since 2000.This crisis no longer knows borders. Now is the time to act—before we lose ground that cannot easily be regained.HIV Prevention Saves Lives—We Must Not Step BackHIV prevention is one of the most cost-effective and impactful investments in global health. It reduces new infections, alleviates the burden on healthcare systems, and safeguards the well-being of vulnerable communities. U.S. government funding for global HIV programs has been a lifeline for communities disproportionately affected by HIV, including women and children, LGBTQ people, sex workers, and people who use drugs. Yet today, political and financial pressures threaten these programs, putting lives and progress in jeopardy.HIV prevention includes a broad range of essential interventions:Access to PrEP (Pre-Exposure Prophylaxis): A highly effective HIV prevention medication that significantly reduces the risk of transmission.Comprehensive sexual health education: Ensuring individuals have the knowledge and resources to protect themselves and their partners.Harm reduction services: Including needle exchange programs and opioid substitution therapy for people who use drugs.Access to condoms and lubricants: Fundamental tools in preventing the spread of HIV and other sexually transmitted infections.HIV testing and linkage to care: Early diagnosis and immediate access to treatment are key to preventing new infections and achieving viral suppression.Mother-to-child transmission prevention: Ensuring pregnant women living with HIV have access to antiretroviral therapy to protect their newborns.HIV, Global Health Security, and Human Rights Are InseparableHIV prevention is not just about health — it is about global stability, economic resilience, and human rights.Slashing funding for HIV programs weakens public health infrastructure, rolling back decades of hard-won progress and making people worldwide more vulnerable to other global health crises.The fight against HIV is intrinsically linked to sexual and reproductive health and rights, women's health, and LGBTQ rights. For example, the lives of transgender individuals are even more at risk due to the reduction of health and human rights-based services as a result of anti-trans and anti-DEI Executive Orders.Women and girls continue to bear a disproportionate burden of the HIV epidemic, and their health hangs in the balance in the wake of funding cuts. Every week, approximately 4,000 adolescent girls and young women contract HIV, the majority of whom live in sub-Saharan Africa. Pregnant women living with HIV require consistent treatment to prevent mother-to-child transmission, yet funding shortfalls place these essential services at risk. Without sustained investment, millions of women and newborns face heightened health risks, undermining global progress toward ending HIV.Governments and donors must recognize that investing in HIV prevention is an investment in global health security. When we protect and strengthen HIV infrastructure, we also reinforce systems that respond to pandemics, reduce maternal mortality, and promote equity in healthcare.A Call to Action: The Time to Step Up is NowWe have the medical tools - including the addition of long-acting injectables - to end HIV as a public health crisis. We just need the funding and leadership.We call on policymakers in the U.S. government and donor governments worldwide to take urgent action:Sustain and increase funding for HIV prevention, treatment, and care. Public investment is essential to protect the communities most at risk and ensure that we don’t lose ground.Recognize the intersection of HIV with broader human rights issues. Supporting HIV programs also means protecting reproductive health, LGBTQ rights, and gender justice.We also call on philanthropy to lean in, not out. Now is not the time for donors to retreat. The role of private philanthropy has never been more critical in safeguarding communities and mobilizing new resources to fill funding gaps. Every investment today saves lives tomorrow.The Kalavai Initiative — a partnership of Funders Concerned About AIDS (FCAA), the International Planned Parenthood Federation (IPPF), Global Philanthropy Project (GPP), and ILGA World — urges all stakeholders to act with urgency. Lives are at stake. The time to protect and expand HIV funding is now.Join Us in Taking ActionPolicymakers, donors, and advocates: Stand with us to protect public health, human rights, and the future of HIV prevention. Together, we can ensure that decades of progress are not lost, and that every person — regardless of who they are or where they live — has access to the lifesaving care they deserve.About the Kalavai Partners:ILGA World is a worldwide federation of more than 2,000 organisations from over 170 countries and territories campaigning for the human rights of people with diverse sexual orientations, gender identities and expressions, and sex characteristics. https://ilga.orgThe International Planned Parenthood Federation (IPPF) is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Founded in 1952, it is now a movement of 150 member associations and collaborative partners with a presence in over 146 countries. https://www.ippf.org/Funders Concerned About AIDS (FCAA) unites philanthropic leaders to pursue a shared vision of a world without AIDS. Through research, advocacy, and collaboration, we work to mobilize and grow funding for the ever-changing fight against HIV. https://www.fcaaids.org/Global Philanthropy Project (GPP) is a collaboration of funders and philanthropic advisors working to expand global philanthropic support to advance the human rights of lesbian, gay, bisexual, transgender, and intersex (LGBTI) people in the Global South and East. https://globalphilanthropyproject.org/

In the wake of World AIDS Day, we reflect on the recent AIDS conference, which convened over 11,000 researchers, policymakers, industry leaders, funders, and civil society representatives united in the fight against HIV and AIDS. IPPF participated with a delegation comprising representatives from its Member Associations and staff, collectively representing 16 countries.  This conference, the largest global gathering on HIV & AIDS, offered a crucial opportunity to explore the latest scientific developments, particularly in bio-medical prevention tools such as the long-acting PrEP injectable and dual prevention pills. Beyond science, the event also provided a platform to examine the wider political and social contexts that continue to impact the global fight against the pandemic.    A grim reality: the numbers speak  Despite decades of progress, the goal of ending HIV by 2030 remains challenging, as underscored by a few sobering statistics:  Someone dies from AIDS-related illnesses every minute  In 2023 alone, 630,000 people died from AIDS-related illnesses  There are still 1.3 million new cases of HIV annually  The fastest-growing rates of HIV are in the MENA region, Latin America, Central Asia, and Eastern Europe  The country with the highest rate of new cases worldwide is Eswatini  These figures serve as a stark reminder of the ongoing impact of HIV on global populations. 

IPPF is concerned by the grave implications that a second Trump Presidency poses to health and human rights in the U.S. and across the world.

On World AIDS Day, we commemorate the remarkable achievements of IPPF Member Associations in their unwavering commitment to combating the HIV epidemic. Their tireless efforts have significantly expanded access to prevention, sexual and reproductive health services, and rights, transforming the lives of countless individuals worldwide. One of the key achievements of IPPF Member Associations has been their ability to expand access to essential sexual and reproductive health services through innovative approaches to HIV prevention, testing, and treatment. By establishing comprehensive service delivery networks and building the capacity of healthcare providers, they have ensured that individuals can access the care they need, regardless of their geographic location or socioeconomic status.   Kazakhstan is facing an urgent public health challenge as the number of HIV infections continues to rise. Over the past decade, the number of people living with HIV has doubled, now surpassing 31,000 individuals. The primary driver of this surge is sexual transmission, which accounts for an alarming 74% of cases. One of the most pressing issues is the high rate of undetected HIV infections. This gap poses significant challenges to implementing effective prevention and control measures. Although testing and treatment services are readily available, deep-rooted societal stigma keeps many from accessing them—particularly young people and key populations who are most vulnerable. Addressing this crisis means confronting the stigma head-on. Reducing the shame and fear surrounding HIV testing is crucial to fostering a culture where individuals feel safe and empowered to seek diagnosis and treatment. By promoting awareness, open conversation, and a supportive environment, we can help break down barriers to care and encourage people to take charge of their health. Only through collective effort can Kazakhstan turn the tide on HIV and prevent its further spread.   Fighting the HIV Pandemic: KMPA's Pioneering Efforts The Kazakhstan Association on Sexual and Reproductive Health (KMPA) is at the forefront of the battle against HIV. In collaboration with the AIDS Center of Astana City, Chevron Munaigaz Inc., and the International Center for AIDS Care and Treatment Programs (ICAP) as well as NGOs working with key population in Astana and youth friendly centers, since August 2023, KMPA has launched two groundbreaking initiatives:

On World AIDS Day, we commemorate the remarkable achievements of IPPF Member Associations in their unwavering commitment to combating the HIV epidemic. Their tireless efforts have significantly expanded access to prevention, sexual and reproductive health services, and rights, transforming the lives of countless individuals worldwide. One of the key achievements of IPPF Member Associations has been their ability to expand access to essential sexual and reproductive health services through innovative approaches to HIV prevention, testing, and treatment. By establishing comprehensive service delivery networks and building the capacity of healthcare providers, they have ensured that individuals can access the care they need, regardless of their geographic location or socioeconomic status.   At the Family Planning Association of Malawi (FPAM), we are not only service providers; we're challenging the status quo. By putting clients at the center of our work and championing innovative solutions, we are fighting for a future where everyone, regardless of their background, has access to the sexual and reproductive health services they deserve. FPAM is committed to delivering evidence-based HIV prevention interventions, including the latest technologies like CAB-LA, an injectable, long-acting form of PrEP. By identifying and engaging with communities and collaborating with organizations, we aim to increase access to these life-saving services and ultimately reducing HIV transmissions. Strengthening Communities, Preventing HIV: Our Commitment  To ensure the successful implementation of these new HIV prevention interventions, at FPAM we have adopted a multifaceted approach. We have identified and prioritized high-risk communities, including men who have sex with men, trans communities, sex worker communities, and young women. By working closely with community-led organizations, we are reaching marginalized populations and addressing their needs. FPAM is committed to fostering strong partnerships to improve access to sexual and reproductive health services, including HIV prevention. By collaborating with government agencies, community-based organizations, and other stakeholders, we are confident in our ability to make a significant impact on HIV prevention and improve the health and well-being of our communities. We have partnered with the Ministry of Health through the Department of HIV, STI and Viral Hepatitis (DHA) to strengthen the capacity of healthcare providers and ensure the availability of essential services. Through joint efforts, we have conducted training sessions with out staff on PrEP, developed guidelines, and implemented quality assurance measures. We have also collaborated with the National AIDS Commission (NAC) on the navigation of prevention programs, especially with the key population whose HIV prevalence is high. By listening to the needs of our communities, we can tailor our interventions to their specific circumstances. Community engagement is at the heart of our approach. We work closely with community-based organizations to reach marginalized populations, address stigma, and promote behavior change. FPAM is working with Men of Tomorrow (MOTO), which works with men. This will be a way of reaching out to Men with PrEP information and services. FPAM will work with Youth Clubs and Community Based Organisations (CBOs) for demand creation and client linkage for PrEP services. FPAM intends to engage the Reproductive Health Directorate to discuss strategies for delivering CAB-LA to breastfeeding and pregnant women. This population has highest knowledge gap on PrEP according to the dialogue sessions that were conducted. By building strong partnerships and leveraging our collective expertise, we are making significant strides in the fight against HIV. Together, we can create a healthier future for all.

On World AIDS Day, we commemorate the remarkable achievements of IPPF Member Associations in their unwavering commitment to combating the HIV epidemic. Their tireless efforts have significantly expanded access to prevention, sexual and reproductive health services, and rights, transforming the lives of countless individuals worldwide. One of the key achievements of IPPF Member Associations has been their ability to expand access to essential sexual and reproductive health services through innovative approaches to HIV prevention, testing, and treatment. By establishing comprehensive service delivery networks and building the capacity of healthcare providers, they have ensured that individuals can access the care they need, regardless of their geographic location or socioeconomic status.   Eswatini has made significant strides in advancing sexual and reproductive health and rights (SRHR). The recent introduction of the dapivirine vaginal ring (DVR) and the potential availability of CAB-LA mark a pivotal moment in the country's HIV prevention efforts. The Dapivirine Vaginal Ring (DVR): A Discreet and Effective Solution The DVR, a discreet and user-friendly monthly ring, has revolutionized HIV prevention. By eliminating the need for daily pill-taking, it has significantly improved adherence rates and reduced the stigma associated with HIV prevention. This groundbreaking innovation has empowered individuals to take control of their sexual health and make informed decisions. The adoption of the dapivirine vaginal ring in Eswatini marked a pivotal step in HIV prevention efforts as the ring offered a discreet and effective alternative to traditional methods. It has offered individuals more options to safeguard their health, expanding accessibility and flexibility in HIV prevention strategies. One of the key contributions that came with the Dapivirine vaginal ring is its monthly application, which has eliminated the need for daily adherence associated with oral PrEP. This simple innovative prevention method has brought in a huge contribution to the Kingdom’s HIV prevention efforts as it has reduced the strict time adherence, enhancing the overall effectiveness of the intervention. In rural areas, the discreet nature of the dapivirine vaginal ring plays a significant role in mitigating the stigma surrounding HIV prevention. Unlike oral medication that may be visible to partners and family members. This discrete form of prevention will encourage more individuals to consider and utilize PrEP without fear of judgement or discrimination.

Eswatini (27 August 2024) - IPPF’s Member Association in Eswatini, the Family Life Association of Eswatini (FLAS), is soon to roll out the first women-controlled HIV prevention product, the dapivirine vaginal ring (DVR). FLAS will be among the first organisations to offer the DVR outside implementation or pilot studies anywhere in the world. Made of flexible silicone, the ring is inserted into the vagina by a woman and slowly releases the antiretroviral drug dapivirine in the vagina over a one-month period, helping to reduce a woman’s risk of acquiring HIV. In 2023, in sub-Saharan Africa, women and girls accounted for 62% of all new HIV infections and every week, 3,100 adolescent girls and young women aged 15–24 years became infected with HIV. Therefore, there continues to be an urgent need for HIV prevention methods that females can use to protect themselves. The DVR is a product women can control themselves and use without the knowledge or consent of their partners, unlike condoms, which men often refuse to use. The DVR is inserted into the vagina and left for a one-month period, where it can then be replaced each month for continued protection. Unlike daily oral PrEP, the DVR does not rely on remembering to take a pill each day and is also discreet as it stays inside the vagina throughout the month. The DVR does not prevent pregnancy or other sexually transmitted infections (STIs), so women choosing to use the ring may want to consider combining it with condoms and methods of contraception. The availability of the DVR is an exciting step in supporting women’s autonomy and choice in HIV prevention. This need for women-controlled HIV prevention products has long been advocated for, with the African Women Prevention Community Accountability Board launching the HIV Prevention Choice Manifesto in early 2023. The Choice Manifesto prioritises the principle of choice to ensure that women and girls have the right to choose which HIV prevention methods work for them. Currently the ring is available at selected facilities through implementation studies across six countries in East and Southern Africa; South Africa, Kenya, Zimbabwe, Lesotho, Eswatini, and Uganda.  Diantha Pillay, Associate Director for Product Access for IPM South Africa NPC (an affiliate of the Population Council), said:  “It is encouraging to see the efforts made by FLAS and IPPF to support the choice agenda for HIV prevention for women and make effective HIV prevention methods, like the DVR, more widely accessible in a real-world setting. We hope this can pave the way for introduction of future pipeline products that speak to the needs of women.” The Population Council is currently developing a longer duration DVR that women would use for three months versus one month to significantly lower annual product costs and offer women a more convenient option to protect themselves. Thabo Lizwe Masuku, Programs Manager for FLAS, said: “Women have been telling us for a long time that  there is a need for a variety of methods for HIV prevention, since they are highly exposed. For women and girls to truly have choice about what works for them as they navigate different stages and circumstances of their lives, policy makers, donors, governments and implementers must ensure the mix of HIV prevention methods are available, accessible, and affordable. Access to the ring through our clinics in Eswatini now gives women choice and options to protect themselves against HIV.” IPPF is committed to ensuring that choice in HIV prevention is a reality for women and girls and aims to roll out the dapivirine vaginal rings at as many Member Associations as possible, as well as offer other HIV-prevention choices, as we work alongside our partners towards a future free of HIV in Africa and beyond. For more information and to speak to staff in Eswatini, please email [email protected]   Notes: The dapivirine vaginal ring has been recommended by the WHO since January 2021. (25) In clinical trials, the  ring was shown to reduce HIV infection by 35% in The Ring Study (26,27) and 27% in the ASPIRE Study. (28,29) Recent open-label studies show greater adherence to the ring, and modelling data suggest that HIV risk could be reduced by about 50%. (30) The dapivirine ring has received regulatory approval from the European Medicines Agency (EMA), as well as from local medicines regulators in Namibia, South Africa, Kenya, Zimbabwe, Uganda, Zambia, Malawi, Rwanda, Eswatini, Lesotho, Botswana and is currently under regulatory review in a number of other countries Our Member Associations (MAs) that provide clinical services are required to provide comprehensive SRH services through our Integrated Package of Essential Services (IPES) which include services for sexual health and well-being, contraception, abortion care, sexually transmitted infections (STIs)/reproductive tract infections (RTIs), HIV, obstetrics and gynaecology, fertility support, and sexual and gender-based violence. IPPF’s new five-year strategy, Come Together, focuses on expanding choice. In support of this, we recently launched a special programme to expand our HIV prevention options, which aims to integrate the newest HIV prevention methods – the vaginal ring and injectable PrEP - into our comprehensive sexual and reproductive health services.  IPPF’s IMAP Statement on Biomedical HIV Prevention can be found here. About the Family Life Association of Eswatini (FLAS)  For over 30 years, the Family Life Association of Eswatini (FLAS) has provided sexual and reproductive health (SRH) services to the people of Eswatini (formally Swaziland). While family planning, antenatal, post-natal and post-abortion care form a key part of FLAS services, there’s a significant focus on HIV and AIDS programmes. Eswatini has some of the highest HIV and AIDS prevalence rates in the world. As a result, the prevention and management of HIV and AIDS, the provision of voluntary counselling and testing (VCT), and the prevention of mother to child transmission (PMTCT) are central to FLAS’s work. FLAS has 15 service points, including three permanent clinics and three mobile facilities, staffed by a permanent team of 40 staff backed by 230 volunteers, 180 Youth Action Movement members and 29 peer educators. About the International Planned Parenthood Federation (IPPF) IPPF is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Led by a courageous and determined group of women, IPPF was founded in 1952 at the Third International Planned Parenthood Conference. Today, we are a movement of 150 Member Associations and Collaborative Partners with a presence in over 146 countries.Our work is wide-ranging, including comprehensive sex education, provision of contraceptives, safe abortion, and maternal care and responding to humanitarian crises.  We pride ourselves on being local through our members and global through our network. At the heart of our mission is the provision of – and advocacy in support of – integrated healthcare to anyone who needs it regardless of race, gender, sex, income, and crucially no matter how remote. Our services are available to all, and reach the most marginalised groups in societies, including key and priority populations, youth, and people with disabilities. Most of our MAs have special programs to engage youth (10-24) inside and outside of school settings. Because our clinics offer comprehensive services, attending our clinics is non-stigmatizing and does not label people as having a particular disease or membership to a particular group. This model of services that are integrated and open to all, embedded in indigenous, locally owned organisations, is ideal for ensuring that the most vulnerable and marginalised groups can access the HIV prevention services they need. About the Population Council The Population Council is a leading research organization dedicated to building an equitable and sustainable world that enhances the health and well-being of current and future generations. The Council transforms global thinking on critical health and development issues through social science, public health, and biomedical research. We generate ideas, produce evidence, and design solutions to improve the lives of underserved populations around the world.  

Recognizing the significant global impact of sexually transmitted infections (STIs), this statement affirms IPPF’s commitment to people-centred STI care as a critical aspect of comprehensive sexual and reproductive health and well-being. A holistic approach to sexual and reproductive health and rights acknowledges that true sexual and reproductive well-being extends beyond the prevention and treatment of diseases. It emphasizes the importance of promoting healthy, satisfying sexual and reproductive experiences. This includes advocating for personcentred care, encouraging self-care strategies, and supporting the development of innovative healthcare delivery models tailored to meet the diverse needs of individuals in various circumstances and contexts, particularly reaching those who are often excluded and marginalized. This statement updates the latest information on STIs. It provides practical recommendations for IPPF Member Associations on how to develop a comprehensive, people-centred approach to STI care, emphasizing integrated services, adherence to guidelines, rights-based care, community engagement, advocacy, and a positive perspective on sexual health and well-being.